Scinovex
review Open AccessTop 1% cited

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Cell Metabolism · 2018 · Vol. 27(4) · pp. 740–756
Daniel J. Drucker
Diabetes Treatment and ManagementPancreatic function and diabetesDiet and metabolism studiesGastric emptyingGlucagon-like peptide-1Enteroendocrine cellAppetiteGlycemicMedicineType 2 diabetesGlucagon-like peptide-2Glucagon-like peptide 1 receptorPharmacology

MeSH terms

Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsAnimalsBlood GlucoseDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2EatingHumansHypoglycemic AgentsInsulinObesityWeight GainMiceRatsGlucagon-Like Peptide 1

Funding

  • Canadian Institutes of Health Research
Citations
1,752
FWCI
69.77
field-weighted impact
References
142
Percentile
100%
vs. same field & year
Citations per year
Cited by
Therapeutic intervention for type 5 diabetes mellitus: an overview
International Journal of Pharmaceutical and Clinical Research · 2025 · 0 citations
Reviewing the therapeutic potential of Myricetin in diabetes and neurodegeneration
Journal of Pharmacognosy and Phytochemistry · 2025 · 0 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.